Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

for the International Vidaza High-Risk MDS Survival Study Group

Research output: Contribution to journal › Article › peer-review

1808 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study'. Together they form a unique fingerprint.

Medicine & Life Sciences